127 related articles for article (PubMed ID: 498163)
1. The treatment of advanced and recurrent Hodgkin's disease with chlorambucil, vinblastine, procarbazine and prednisone in combination.
Stout R; Todd ID
Cancer Treat Rev; 1979 Jun; 6 Suppl():107-13. PubMed ID: 498163
[No Abstract] [Full Text] [Related]
2. BCNU, velban, cyclophosphamide, procarbazine, and prednisone (BVCPP) in advanced Hodgkin's disease.
Durant JR; Gams RA; Velez-Garcia E; Bartolucci A; Wirtschafter D; Dorfman R
Cancer; 1978 Nov; 42(5):2101-10. PubMed ID: 719600
[No Abstract] [Full Text] [Related]
3. [Treatment maintaining complete remission in Hodgkin's disease].
Armata J
Pol Tyg Lek; 1981 Feb; 36(8):301-4. PubMed ID: 7022410
[No Abstract] [Full Text] [Related]
4. Combination chemotherapy in advanced and recurrent Hodgkin's disease.
McElwain TJ; Wrigley PF; Hunter A; Crowther D; Malpas JS; Peckham MJ; Smithers DW; Fairley GH
Natl Cancer Inst Monogr; 1973 May; 36():395-402. PubMed ID: 4744597
[No Abstract] [Full Text] [Related]
5. Alternating chemotherapy and irradiation in the treatment of advanced Hodgkin's disease.
Hoppe RT; Portlock CS; Glatstein E; Rosenberg SA; Kaplan HS
Cancer; 1979 Feb; 43(2):472-81. PubMed ID: 369676
[No Abstract] [Full Text] [Related]
6. Chlorambucil, vinblastine, procarbazine, and prednisone. An effective but less toxic regimen than MOPP for advanced-stage Hodgkin's disease.
Druker BJ; Rosenthal DS; Canellos GP
Cancer; 1989 Mar; 63(6):1060-4. PubMed ID: 2917308
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy of Hodgkin's disease.
Malpas JS
J R Coll Physicians Lond; 1980 Jan; 14(1):26-33. PubMed ID: 6160241
[No Abstract] [Full Text] [Related]
8. Prognosis of Hodgkin's disease: patients who fail to remit or who relapse after combination chemotherapy.
Sutcliffe SB; Economopoulos T; Wrigley PF; Stansfeld AG; Malpas JS
Clin Oncol; 1980 Dec; 6(4):329-36. PubMed ID: 6161731
[No Abstract] [Full Text] [Related]
9. Low dose radiation therapy and combination chemotherapy in the treatment of advanced Hodgkin's disease.
Prosnitz LR; Farber LR; Fischer JJ; Bertino JR
Radiology; 1973 Apr; 107(1):187-93. PubMed ID: 4689429
[No Abstract] [Full Text] [Related]
10. Hodgkin's disease.
Saven A
N Engl J Med; 1992 Aug; 327(7):499; author reply 499-500. PubMed ID: 1625747
[No Abstract] [Full Text] [Related]
11. [Treatment outcome of advanced Hodgkin's disease based on using an alternating program ChLVPP (chlorambucil, vinblastine, procarbazine, prednisone) and ABV (doxorubicin, bleomycin, vinblastine)].
Komarnicki M; Balcerzak A; Górski P; Pawlak L; Hansz J
Acta Haematol Pol; 1994; 25(4):363-8. PubMed ID: 7531381
[TBL] [Abstract][Full Text] [Related]
12. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy of Hodgkin's disease in studies by acute leukemia group B.
Nissen NI; Stutzman L; Holland JF; Glidewell OJ
Arch Intern Med; 1973 Mar; 131(3):396-401. PubMed ID: 4688038
[No Abstract] [Full Text] [Related]
14. ChlVPP--an effective and well-tolerated alternative to MOPP therapy for Hodgkin's disease.
Vose J; Armitage J; Weisenburger D; Moravec D; Hutchins M; Howe D; Sorensen S; Dowling M; Okerbloom J; Pevnick W
Am J Clin Oncol; 1988 Aug; 11(4):423-6. PubMed ID: 3407620
[TBL] [Abstract][Full Text] [Related]
15. Alternating drug combinations for advanced Hodgkin's disease.
N Engl J Med; 1982 Sep; 307(11):687-9. PubMed ID: 6180317
[No Abstract] [Full Text] [Related]
16. More than MOPP for advanced Hodgkin's disease?
Mayer RJ
N Engl J Med; 1982 Apr; 306(13):800-2. PubMed ID: 6174866
[No Abstract] [Full Text] [Related]
17. Treatment of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD).
Papa G; Mandelli F; Anselmo AP; De Luca AM; Maurizienrici R; Mauro F; Testi AM; Amadori S; Biagini C
Eur J Cancer Clin Oncol; 1982 Sep; 18(9):803-6. PubMed ID: 6185342
[No Abstract] [Full Text] [Related]
18. A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's disease.
Cooper MR; Pajak TF; Nissen NI; Stutzman L; Brunner K; Cuttner J; Falkson G; Grunwald H; Bank A; Leone L; Seligman BR; Silver RT; Weiss RB; Haurani F; Blom J; Spurr CL; Glidewell OJ; Gottlieb AJ; Holland JF
Cancer; 1980 Aug; 46(4):654-62. PubMed ID: 7397630
[TBL] [Abstract][Full Text] [Related]
19. Three years' experience with Ch1VPP (a combination of drugs of low toxicity) for the treatment of Hodgkin's disease.
Kaye SB; Juttner CA; Smith IE; Barrett A; Austin DE; Peckham MJ; McElwain TJ
Br J Cancer; 1979 Feb; 39(2):168-74. PubMed ID: 435366
[TBL] [Abstract][Full Text] [Related]
20. A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease.
McElwain TJ; Toy J; Smith E; Peckham MJ; Austin DE
Br J Cancer; 1977 Aug; 36(2):276-80. PubMed ID: 911666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
